Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria, Wojtaszko"'
Autor:
Aleksander B. Skotnicki, Malgorzata Calbecka, Krzysztof Warzocha, Maria Wojtaszko, Janusz Kloczko, Jadwiga Dwilewicz-Trojaczek, Marek Kasznicki, Kazimierz Sulek, Barbara Zdziarska, Krystyna Zawilska, Jacek Dybowicz, Wieslaw Nowak, Ilona Seferynska, Krzysztof Gawronski, Lucyna Molendowicz-Portala, Anna Dmoszynska, Bernardeta Ceglarek, Krzysztof Jamroziak, Aleksandra Kostyra, Tadeusz Robak, Joanna Gora-Tybor, Andrzej Zdunczyk, Lech Konopka, Beata Stella-Holowiecka, Jaroslaw Sokolowski, Jerzy Z. Blonski, Krzysztof Lewandowski, Elżbieta Wiater, Andrzej Hellmann
Publikováno v:
Blood. 109:3672-3675
Cladribine (2-chlorodeoxyadenosine, 2-CdA) treatment-associated infections may shorten potentially long-term survival in hairy cell leukemia (HCL). In search of the optimal mode of 2-CdA administration, 132 patients with untreated HCL were randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8df63087135f8454b9973a5dd44bc8a3
https://doi.org/10.1182/blood-2006-08-042929
https://doi.org/10.1182/blood-2006-08-042929
Autor:
Tadeusz, Robak, Jerzy Z, Błoński, Marek, Kasznicki, Joanna, Góra-Tybor, Anna, Dmoszyńska, Maria, Wojtaszko, Aleksander B, Skotnicki, Wiesław, Nowak, Andrzej, Hellmann, Krzysztof, Lewandowski, Barbara, Zdziarska, Lech, Konopka, Bernadetta, Ceglarek, Jadwiga, Dwilewicz-Trojaczek, Piotr, Boguradzki, Kazimierz, Kuliczkowski, Kazimierz, Sułek, Krzysztof, Warzocha
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 11(10)
We previously published an early report of a randomized, multicenter trial on the efficacy and toxicity of cladribine (2-CdA) + prednisone (P) compared with chlorambucil (Chl) + P in previously untreated patients with progressive or symptomatic chron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40a52378ae4c5ab1a8501231380668aa
https://pubmed.ncbi.nlm.nih.gov/16192912
https://pubmed.ncbi.nlm.nih.gov/16192912
Autor:
Tadeusz Robak, Krzysztof Jamroziak, Joanna Gora-Tybor, Jerzy Z. Blonski, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Andrzej Hellmann, Beata Stella-Holowiecka, Kazimierz Sulek, Aleksander B. Skotnicki, Krystyna Zawilska, Janusz Kloczko, Ilona Seferynska, Lech Konopka, Jaroslaw Piszcz, Berandetta Ceglarek, Krzysztof Lewandowski, Krzysztof Gawronski, Aleksandra Kostyra, Wieslaw Nowak, Elzbieta Wiater, Jacek Dybowicz, Lucyna Molendowicz-Portala
Publikováno v:
Blood. 108:2485-2485
Cladribine (2-chlorodeoxyadenosine, 2-CdA) has dramatically improved prognosis of hairy cell leukemia (HCL), though the 2-CdA treatment-associated life-threatening infections may shorten potentially long-term survival of HCL patients. In search of op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6ccae0f7aa49665a1d6af2baeca2d05
https://doi.org/10.1182/blood.v108.11.2485.2485
https://doi.org/10.1182/blood.v108.11.2485.2485
Autor:
Lech Konopka, Janusz Kloczko, Barbara Zdziarska, Anna Dmoszynska, Aleksander B. Skotnicki, Maria Wojtaszko, Andrzej Hellmann, Joanna Gora-Tybor, Jadwiga Dwilewicz-Trojaczek, Beata Stella-Holowiecka, Marek Kasznicki, Malgorzata Calbecka, Kazimierz Sulek, Krystyna Zawilska, Krzysztof Warzocha, Tadeusz Robak
Publikováno v:
Blood. 104:3478-3478
Cladribine is the drug of choice in the treatment of hairy cell leukemia (HCL). However, its optimal method of administration is still unknown. There are suggestions that weekly administration is less toxic than daily schedule. We, therefore, compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b636af6b3232497160fb84e75299ae2
https://doi.org/10.1182/blood.v104.11.3478.3478
https://doi.org/10.1182/blood.v104.11.3478.3478
Autor:
Joanna Gora-Tybor, Piotr Boguradzki, Kazimierz Kuliczkowski, Barbara Zdziarska, Jadwiga Dwilewicz-Trojaczek, Wieslaw Nowak, Lech Konopka, Bernadeta Ceglarek, Marek Kasznicki, Kazimierz Sulek, Andrzej Hellmann, Tadeusz Robak, Anna Dmoszynska, Krzysztof Warzocha, Maria Wojtaszko, Aleksander B. Skotnicki, Jerzy Z. Blonski, Krzysztof Lewandowski
Publikováno v:
ResearcherID
Previously, we reported a study on efficacy and toxicity of cladribine (2-CdA) + prednisone (P) compared with chlorambucil (Chl) + P in previously untreated patients with progressive or symptomatic chronic lymphocytic leukemia (CLL) in a randomized m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782593f031f613c9adf726a0c1e2a252
https://doi.org/10.1182/blood.v104.11.4819.4819
https://doi.org/10.1182/blood.v104.11.4819.4819